These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 14978182)

  • 21. Familial hemolytic-uremic syndrome and homozygous factor H deficiency.
    Pichette V; Quérin S; Schürch W; Brun G; Lehner-Netsch G; Delâge JM
    Am J Kidney Dis; 1994 Dec; 24(6):936-41. PubMed ID: 7985673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.
    Schejbel L; Schmidt IM; Kirchhoff M; Andersen CB; Marquart HV; Zipfel P; Garred P
    Genes Immun; 2011 Mar; 12(2):90-9. PubMed ID: 21270828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
    Nozal P; Garrido S; Alba-Domínguez M; Espinosa L; Peña A; Córdoba SR; Sánchez-Corral P; López-Trascasa M
    Mol Immunol; 2014 Apr; 58(2):194-200. PubMed ID: 24378252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incomplete hemolytic uremic syndrome associated with partial factor H deficiency].
    Olaciregui Echenique I; Areses Trapote R; Ubetagoyena Arrieta M; Sota Busselo I; García Pardos C; Echaniz Aizpuru P
    An Pediatr (Barc); 2007 Feb; 66(2):188-90. PubMed ID: 17306107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
    Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
    Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.
    Dragon-Durey MA; Loirat C; Cloarec S; Macher MA; Blouin J; Nivet H; Weiss L; Fridman WH; Frémeaux-Bacchi V
    J Am Soc Nephrol; 2005 Feb; 16(2):555-63. PubMed ID: 15590760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attempted treatment of factor H deficiency by liver transplantation.
    Cheong HI; Lee BS; Kang HG; Hahn H; Suh KS; Ha IS; Choi Y
    Pediatr Nephrol; 2004 Apr; 19(4):454-8. PubMed ID: 14986080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement factor H and the hemolytic uremic syndrome.
    Atkinson JP; Goodship TH
    J Exp Med; 2007 Jun; 204(6):1245-8. PubMed ID: 17548524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C; Zaloszyc A; Licht C; Pichault V; Frémeaux-Bacchi V; Fischbach M
    Pediatr Nephrol; 2016 Jan; 31(1):157-61. PubMed ID: 26399238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.
    Caprioli J; Bettinaglio P; Zipfel PF; Amadei B; Daina E; Gamba S; Skerka C; Marziliano N; Remuzzi G; Noris M
    J Am Soc Nephrol; 2001 Feb; 12(2):297-307. PubMed ID: 11158219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.
    Tortajada A; Pinto S; Martínez-Ara J; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Kidney Int; 2012 Jan; 81(1):56-63. PubMed ID: 21881555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
    Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
    Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The autoimmune disease DEAP-hemolytic uremic syndrome.
    Skerka C; Zipfel PF; Müller D; Micklisch S; Riedl M; Zimmerhackl LB; Hofer J
    Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
    Ståhl AL; Vaziri-Sani F; Heinen S; Kristoffersson AC; Gydell KH; Raafat R; Gutierrez A; Beringer O; Zipfel PF; Karpman D
    Blood; 2008 Jun; 111(11):5307-15. PubMed ID: 18268093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic studies into inherited and sporadic hemolytic uremic syndrome.
    Warwicker P; Goodship TH; Donne RL; Pirson Y; Nicholls A; Ward RM; Turnpenny P; Goodship JA
    Kidney Int; 1998 Apr; 53(4):836-44. PubMed ID: 9551389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13.
    Michael M; Turner N; Elenberg E; Shaffer LG; Teruya J; Arar M; Hui SK; Smith RJ; Moake J
    Clin Kidney J; 2018 Dec; 11(6):791-796. PubMed ID: 30524124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells.
    Heinen S; Józsi M; Hartmann A; Noris M; Remuzzi G; Skerka C; Zipfel PF
    J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.